Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,505.00
+140.00 (4.16%)
At close: Mar 6, 2026

Pharmsville Revenue

Pharmsville had revenue of 3.37B KRW in the quarter ending September 30, 2025, a decrease of -20.69%. This brings the company's revenue in the last twelve months to 13.36B, down -25.46% year-over-year. In the year 2024, Pharmsville had annual revenue of 16.72B, down -21.83%.

Revenue (ttm)
13.36B
Revenue Growth
-25.46%
P/S Ratio
1.96
Revenue / Employee
477.13M
Employees
28
Market Cap
26.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.72B-4.67B-21.83%
Dec 31, 202321.39B-4.72B-18.07%
Dec 31, 202226.11B-12.91B-33.09%
Dec 31, 202139.03B-381.05M-0.97%
Dec 31, 202039.41B9.46B31.57%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ChoA Pharmaceutical Co., LTD. 60.50B
Hurum 95.37B
Seoul Pharma 52.43B
Daesung Microbiological Labs. 25.86B
BIFIDO 18.65B
WooGene B&G 54.77B
Union Korea Pharm 33.83B
HLscience 18.10B
Revenue Rankings